Skip to main content

CORRECTION article

Front. Endocrinol., 16 August 2022
Sec. Diabetes: Molecular Mechanisms
Volume 13 - 2022 | https://doi.org/10.3389/fendo.2022.981231

Corrigendum: ASK1-interacting protein 1 acts as a novel predictor of type 2 diabetes

This article is a correction to:

  1. ASK1-Interacting Protein 1 Acts as a Novel Predictor of Type 2 Diabetes

    1. Read original article
Zhigao Song,&#x;Zhigao Song1,2†Cong Chen&#x;Cong Chen1†Jipei HeJipei He3Bixia LiuBixia Liu1Weidong Ji*Weidong Ji1*Liangping Wu,*Liangping Wu3,4*Li He,*Li He1,5*
  • 1Center for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
  • 2Department of Cardiovascular Surgery, Zhujiang Hospital of Southern Medical University, Guangzhou, China
  • 3Department of Metabolic Surgery, Your Doctor Medical Group, Guangzhou, China
  • 4Department of Metabolic Surgery, Jinshazhou Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, China
  • 5Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China

A Corrigendum on
ASK1-interacting protein 1 acts as a novel predictor of type 2 diabetes

By Song Z, Chen C, He J, Liu B, Ji W, Wu L and He L (2022). Front. Endocrinol. 13:896753. doi: 10.3389/fendo.2022.896753

Error in author list

In the published article, there was an error in the author list, and author Weidong Ji 1 was erroneously cited. The corrected author list appears below.

Zhigao Song 1,2†, Cong Chen 1†, Jipei He 3, Bixia Liu 1, Weidong Ji 1*, Liangping Wu 3,4* and Li He 1,5*

The authors apologize for this error and state that this does not change the scientific conclusiosns of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: AIP1, visceral adipose, adipose inflammation, insulin resistance, type 2 diabetes

Citation: Song Z, Chen C, He J, Liu B, Ji W, Wu L and He L (2022) Corrigendum: ASK1-interacting protein 1 acts as a novel predictor of type 2 diabetes. Front. Endocrinol. 13:981231. doi: 10.3389/fendo.2022.981231

Received: 29 June 2022; Accepted: 28 July 2022;
Published: 16 August 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Song, Chen, He, Liu, Ji, Wu and He. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Li He, heli55@mail.sysu.edu.cn; Liangping Wu, drwulp@163.com; Weidong Ji, jiweidong@mail.sysu.edu.cn

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.